Polyphotonix

Developer of photonic technology-based devices to treat diabetic retinotherapy

placeSedgefield, England, United Kingdom calendar_todayFounded 2008 groups8 employees language polyphotonix.com

Registered entities

Innovation

14 patent families (5 granted) — focus: Human necessities, Electricity & electronics, Operations & transport; filing pace slowing. Cited 429 times.

YearFilings
20137
20146
20155
20165
20174
20182
20191
20203
20213
20232
20241
20251

Social engagement

Social engagement: 856 social following, 9 posts in the last 12 months — above the industry median.

Investor mix

1 investor on record; lead investors include Prevail Partners.

Investor typeCountShare
Venture capital1100%

Recent activity

24 Jun 2026
Event
Trend Diabetes National Conferences
21 Jun 2026
Product launch
Noctura 400
15 Jun 2026
Event
Trend Diabetes Newcastle
Coming soon